These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dopamine transporter as target for drug development of cocaine dependence medications. Dutta AK; Zhang S; Kolhatkar R; Reith ME Eur J Pharmacol; 2003 Oct; 479(1-3):93-106. PubMed ID: 14612141 [TBL] [Abstract][Full Text] [Related]
6. Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. Enyedy IJ; Sakamuri S; Zaman WA; Johnson KM; Wang S Bioorg Med Chem Lett; 2003 Feb; 13(3):513-7. PubMed ID: 12565962 [TBL] [Abstract][Full Text] [Related]
8. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167 [TBL] [Abstract][Full Text] [Related]
9. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Rothman RB; Dersch CM; Carroll FI; Ananthan S Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522 [TBL] [Abstract][Full Text] [Related]
11. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653 [TBL] [Abstract][Full Text] [Related]
12. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain. De La Garza R; Meltzer PC; Madras BK Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines. Ananthan S; Saini SK; Khare R; Clayton SD; Dersch CM; Rothman RB Bioorg Med Chem Lett; 2002 Aug; 12(16):2225-8. PubMed ID: 12127543 [TBL] [Abstract][Full Text] [Related]
14. 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors. Sakamuri S; Enyedy IJ; Zaman WA; Tella SR; Kozikowski AP; Flippen-Anderson JL; Farkas T; Johnson KM; Wang S Bioorg Med Chem; 2003 Mar; 11(6):1123-36. PubMed ID: 12614900 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters. Meltzer PC; Pham-Huu DP; Madras BK Bioorg Med Chem Lett; 2004 Dec; 14(24):6007-10. PubMed ID: 15546718 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation. Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035 [TBL] [Abstract][Full Text] [Related]
19. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter. Bonnet JJ Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150 [TBL] [Abstract][Full Text] [Related]
20. Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter. Feng X; Fandrick K; Johnson R; Janowsky A; Cashman JR Bioorg Med Chem; 2003 Mar; 11(5):775-80. PubMed ID: 12538008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]